Has Elias Zias, MD received payments from drug or device companies?

Yes. Drug and device makers reported $465,500 in general payments to Elias Zias, MD across 405 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Elias Zias, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Elias Zias, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Elias Zias, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · New York, NYNPI 1104879832

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (56.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Abiomed accounts for 71.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $105,814 and has fallen 65.4% since, to $36,632 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$465,500in general payments, 2019–2025

Across 405 payments — averaging $1149.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abiomed$334K
Atricure, Inc.$110K
Johnson & Johnson$16K
Edwards Lifesciences$4K
Medical Device Business Services, Inc.$824
Baxter Healthcare$182
plus $95 from 4 others

$129,793in research payments, 2019–2025

Across 17 payments — averaging $7634.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Atricure, Inc.$130K

What the payments were for

Consulting fees$129,89828%
Speaking & faculty fees$261,95056%
Travel & lodging$61,88413%
Food & beverage$11,7683%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abiomed	210	$334,312
Atricure, Inc.	141	$110,336
Johnson & Johnson(2 entities)	4	$15,898
Edwards Lifesciences	39	$3,853
Medical Device Business Services, Inc.	1	$824
Baxter Healthcare	6	$182
E.r. Squibb & Sons, L.L.C.	1	$36
Zimmer Biomet	1	$22
Medtronic	1	$21
Bolton Medical Inc	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Impella$313,743
SYNERGY ABLATION SYSTEM$41,959
ATRICURE SYNERGY ABLATION SYSTEM$36,697
PROLENE$31,720
ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$26,934
ATRICURE ATRICLIP LAA EXCLUSION$22,602
ATRICLIP LAA EXCLUSION SYSTEM$18,364
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$16,118
VISTASEAL$12,810
ISOLATOR SURGICAL ABLATION SYSTEM$8,372
DISSECTOR$8,139
DERMABOND$3,050
STRATAFIX$3,050
LARIAT SUTURE DELIVERY DEVICE$150
EPI-SENSE GUIDED COAGULATION SYS$115
ATRICURE CRYOSURGICAL SYSTEM$108

How this compares

$465,500 in reported general payments places this provider in the 95th percentile of 383 thoracic surgery (cardiothoracic vascular surgery) providers in New York.

See all thoracic surgery (cardiothoracic vascular surgery) providers in New York →

Medicare billing

Part B allowed, 2024

$79,819

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metoprolol Succinate	26	$129

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in New York

Aubrey GallowayNew York$5.7M
Gilbert TangNew York$842K
Michael ZervosNew York$811K
Isaac GeorgeNew York$395K
Eugene GrossiNew York$350K
Costas BizekisNew York$321K
Brendon StilesNew York$314K
Daniela MolenaNew York$221K
Arnar GeirssonNew York$218K
Andrea WolfNew York$157K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →